India extends shelf life of AstraZeneca vaccine: Report

India's drug regulator has allowed the AstraZeneca Covid-19 vaccine to be used for up to nine months from its manufacture date, as opposed to the prescribed six months, according to a document reviewed by Reuters and a source. The approval, given to a licensed version of the drug made by Serum Institute of India could help minimise vaccine wastage and improve inoculation drive.

from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/3cC3d5A
via IFTTT